1 Nov 2007Review
The management of obstructive jaundice in pancreatic cancer.
Cosimo Sperti 1Laura Frison 1Guido Liessi 2Sergio Pedrazzoli 1
Affiliations
Article Info
1 Dipartimento di Scienze Mediche e Chirurgiche, Clinica Chirurgica IV, Università di Padova; Istituto Oncologico Veneto
2 U.0. di Radiologia, Ospedale di Castelfranco Veneto, Treviso
Ann. Ital. Chir., 2007, 78(6), 469-474;
Published: 1 Nov 2007
Copyright © 2007 Annali Italiani di Chirurgia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Patients with pancreatic cancer often present with advanced disease; so, curative surgical resection is possible in a small number of patients. Palliation in these patients focuses particularly on relief of biliary obstruction. Palliative treatment modalities include both surgical and nonsurgical approaches. Biliary obstruction is initially treated with endoscopic biliary stenting, plastic or metallic stents. Both of these provide similar initial relief of biliary obstruction; however, plastic stents have a greater risk of occlusion and should be used in patients with short survival duration. Metallic stents have a greater initial cost, but provide an overall costsaving in patients with expected survival more than 6 months. There is no evidence of benefit from routine stenting of jaundiced patients before resection. Surgical palliation for biliary obstruction should be primarily considered in patients who fail endoscopic or percutaneous biliary decompression or who develop gastroduodenal obstruction, It is also indicated for patients with good performance status and expected survival of over 6 months. Surgical decompression of biliary tree should be made with a choledochojejunostomy whenever feasible, associated to a gastroduodenal bypass.
Keywords
- Obstructive jaundice
- Palliative treatment
- Pancreatic cancer